Career Center

SoMCC Event



Industry Insights - China, A New Land of Opportunities for Medical and Life Science Professionals


Date:   Wednesday, May 11, 2011

Time:   12:00 -1:00 PM (Presentation and Q&A)
1:00-1:30 PM (Informal reception)

Location:   LKSC 130

Sponsors:   School of Medicine Career Center (SoMCC)

Event details:  

China is rapidly becoming a global leader in drug discovery and innovation.  Based on a recent report by IMS Health, the drug market in China is projected to grow 25 to 27 percent in 2011 to more than $50 billion, and to become the world's second-largest biopharmaceutical market by 2012.  The massive return of at least 80,000 Western-trained PhDs in life sciences in recent years will undoubtedly accelerate the pace of growth in China over the next decade.   What are the implications of such massive economic growth for the biotechnology and healthcare industry?  How does this impact the operations of both large and small biotech companies and service firms? How does this translate into a new and exciting array of opportunities for medical and life science professionals? 

In this session, you will hear from a panel of seasoned experts who collectively represent dozens of years of experience in life science and possess great knowledge about the state of the life science industry and new opportunities in China.  Each of these guest speakers has achieved significant expertise and distinction, in areas of basic research, clinical development, business, and legal services.  During this session, the experts will discuss how US-based life science companies are positioning themselves to embrace new opportunities in China.  They will also share their insights into how today’s life science research trainees can best prepare for the emerging business and career opportunities as well as unique challenges they will likely face in this new “land of opportunity.”

About our panelists:

Dr. Wei Dong is current the President of CABS. She holds a PhD in Epidemiology from the London School of Hygiene and Tropical Medicine, University of London, UK, and a MD from Shanghai Medical School, P.R. China. Wei has over 15 years experience spanning biotech industry and academia in the USA and the UK. Currently, Wei is the Global Head of Epidemiology for Oncology at Genentech (a member of the Roche Group). Previously, she was in academia as an Assistant Professor in Epidemiology at the Mount Sinai School of Medicine in New York, USA and a Lecturer in Epidemiology at the University College London Medical School, UK.

Dr. Shichang Miao, is the immediate past president of CABS. Dr. Miao is currently Senior Director, Discovery & Clinical Drug Metabolism / Pharmacokinetics at ChemoCentryx Inc., a Mountain View, California-based biotech company focusing on the discovery and development of drugs though regulation of chemokine receptors. Until May 2007, he was a director in the pharmacokinetics and drug metabolism department at Amgen South San Francisco. He worked at Tularik Inc. from 1994 through 2004 (most recently as Associate Director, Analytical Chemistry and Drug Metabolism) until Tularik's acquisition by Amgen. He obtained his Ph.D. in organic chemistry/ natural products chemistry from the University of British Columbia (Vancouver , Canada ) in 1991 and carried out postdoctoral research in organic synthesis/natural products chemistry at the University of Alberta and in proteomics at the University of British Columbia.

Dr. Janet (Jian) Xiao, is the President Elect of CABS, and has been a patent attorney in the Palo Alto office of Morrison & Foerster LLP since 2003. She primarily represents clients in areas of biotechnology and pharmaceutical industry in their world-wide patent procurement, patent portfolio management, and strategic planning. Dr. Xiao has significant experience in analyzing complex patent portfolios as well as mining and strengthening her client's patent portfolio. Besides patent prosecution, her practice includes patent reexamination, patent litigation, preparation of freedom-to-operate opinions, and due diligence. Dr. Xiao received a B.S. in Chemistry from Nanjing University, a M.S. in Molecular Biology from Institute of Biophysics, Chinese Academy of Sciences, and a Ph.D. in Biological Chemistry from UCLA. She received her J.D. from the Boalt Hall School of Law at the University of California, Berkeley, where she graduated with a Law and Technology Certificate and received a Moot Court Advocacy Award. She has authored and co-authored numerous legal and scientific publications. Dr. Xiao currently serves as the co-chair of the CABS International Collaboration Committee.

Dr. Cheni Kwok, CLPTM, Senior Vice President, Corporate Development joined Poniard Pharmaceuticals in July 2006 as the Vice President of Business Development. She established corporate and business development, strategic and commercial planning, new product planning, competitive intelligence and forecasting functions at Poniard. Previously, Dr. Kwok was Director of Business Development at Celera Genomics from 2004 to 2006, where she led the business development efforts for Celera's small molecule therapeutics programs. Prior to Celera, Dr. Kwok held business development positions of increasing responsibility for Exelixis Inc. from 2000 to 2004, where she initiated multiple partnerships and served as the alliance manager for the GlaxoSmithKline collaboration. Prior to joining Exelixis Inc., Dr. Kwok held various research management, technology assessment and alliance management roles at SmithKline Beecham Pharmaceuticals from 1997 to 2000. She received a bachelor's degree in biotechnology from Imperial College of Science, Technology and Medicine, University of London, UK and a Ph.D. in human molecular genetics from the University of Cambridge, UK. Dr. Kwok obtained the Certified Licensing Professional (CLPTM) credential established by the Licensing Executive Society (USA and Canada).

CABS is the Chinese American BioPharmaceutical Society (C.A.B.S.)

Free and open to Stanford ID holders.
Additional information and/or registration:   RSVP required. Space is limited, register online

Footer Links: